Case Reports
doi: 10.1002/1097-0142(19830201)51:3<426::aid-cncr2820510312>3.0.co;2-s.
Acute cerebellar dysfunction with high-dose ARA-C therapy
- PMID: 6571798
- DOI: 10.1002/1097-0142(19830201)51:3<426::aid-cncr2820510312>3.0.co;2-s
Item in Clipboard
Case Reports
Acute cerebellar dysfunction with high-dose ARA-C therapy
Cancer.
.
Abstract
The authors report a patient with clinical and morphologic evidence of acute cerebellar toxicity after receiving high-dose cytosine arabinoside (ARA-C) (3000 mg/m2/12 hours) for refractory AML. Damage of Purkinje cells and dentate nucleus was demonstrated. Reversible cerebellar toxicity has previously been noted in patients on an identical regimen. Signs of cerebellar dysfunction mandate immediate cessation of high-dose ARA-C therapy.
Similar articles
-
Severe persistent cerebellar dysfunction complicating cytosine arabinoside therapy.Acta Med Scand. 1988;224(2):189-91. doi: 10.1111/j.0954-6820.1988.tb16760.x. Acta Med Scand. 1988. PMID: 3166602
-
Cytarabine induced cerebellar neuronal damage in juvenile rat: correlating neurobehavioral performance with cellular and genetic alterations.Toxicology. 2012 Mar 11;293(1-3):41-52. doi: 10.1016/j.tox.2011.12.005. Epub 2011 Dec 24. Toxicology. 2012. PMID: 22212197
-
Cerebellar dysfunction during high dose cytosine arabinoside therapy in a case of acute myelogenous leukaemia.Scand J Haematol. 1986 Feb;36(2):165-7. doi: 10.1111/j.1600-0609.1986.tb00822.x. Scand J Haematol. 1986. PMID: 3458292
-
Filamentous degeneration of neurons. A possible feature of cytosine arabinoside neurotoxicity.Cancer. 1993 Feb 15;71(4):1303-8. doi: 10.1002/1097-0142(19930215)71:4<1303::aid-cncr2820710422>3.0.co;2-6. Cancer. 1993. PMID: 8435808 Review.
-
[Bases for intravenous administration of cytosine arabinoside in the treatment of adult acute myeloid leukemia].Bull Cancer. 1995 Nov;82(11):911-22. Bull Cancer. 1995. PMID: 8535017 Review. French.
Cited by
-
Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukemia.Blut. 1986 Oct;53(4):309-14. doi: 10.1007/BF00320890. Blut. 1986. PMID: 3756357
-
Cerebellar toxicity during cytarabine therapy associated with renal insufficiency.Cancer Chemother Pharmacol. 1990;27(1):76-8. doi: 10.1007/BF00689281. Cancer Chemother Pharmacol. 1990. PMID: 2245495 Review.
-
AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity.Int J Hematol. 2008 Nov;88(4):381-386. doi: 10.1007/s12185-008-0171-7. Epub 2008 Oct 4. Int J Hematol. 2008. PMID: 18836794
-
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action.Clin Pharmacokinet. 2020 Dec;59(12):1521-1550. doi: 10.1007/s40262-020-00934-7. Clin Pharmacokinet. 2020. PMID: 33064276 Free PMC article. Review.
-
Drug-induced cerebellar ataxia: a systematic review.CNS Drugs. 2014 Dec;28(12):1139-53. doi: 10.1007/s40263-014-0200-4. CNS Drugs. 2014. PMID: 25391707